"Melbourne, Australia; 20 May 2019: Cynata Therapeutics Limited (ASX: CYP), a clinical-stage biotechnology company specialising in cell therapeutics, announced today that healthcare industry and venture capital veteran, Dr Geoff Brooke, has been appointed as an independent non-executive director to the Board of the Company. Dr Brooke’s 30 years of international experience adds substantial life sciences and financial expertise to the Cynata Board. Dr Brooke is the founder and former Managing Director of two leading life sciences venture capital firms, GBS Ventures and Medvest Inc, as well as the lead investor and Chairman/Director of numerous healthcare companies."
Less than a year ago to the usual CV fanfare, and now first raise...venture capital VETERAN
a shocker! well done Dr Brooke
Ann: Cynata announces $5.55m capital raising, page-53
-
- There are more pages in this discussion • 97 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
-0.005(2.33%) |
Mkt cap ! $37.94M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 21.0¢ | 21.0¢ | $423 | 2.016K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 41003 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 10656 | 1 |
View Market Depth
| Last trade - 12.11pm 27/09/2024 (20 minute delay) ? |
| CYP (ASX) Chart |